These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1238 related items for PubMed ID: 6206157

  • 1. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA, Marlin SD, Schwartz SA, Glorioso JC.
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [Abstract] [Full Text] [Related]

  • 2. Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets.
    Fitzgerald PA, Evans R, Kirkpatrick D, Lopez C.
    J Immunol; 1983 Apr; 130(4):1663-7. PubMed ID: 6601135
    [Abstract] [Full Text] [Related]

  • 3. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
    Colmenares C, Lopez C.
    J Immunol; 1986 May 01; 136(9):3473-80. PubMed ID: 2420891
    [Abstract] [Full Text] [Related]

  • 4. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
    Ritchie MH, Oakes JE, Lausch RN.
    Invest Ophthalmol Vis Sci; 1993 Jul 01; 34(8):2460-8. PubMed ID: 8392037
    [Abstract] [Full Text] [Related]

  • 5. Use of monoclonal antibodies to HSV-1 and HSV-2 for serological analysis of the viral glycoproteins.
    Pereira L.
    Dev Biol Stand; 1982 Jul 01; 52():115-31. PubMed ID: 6299824
    [Abstract] [Full Text] [Related]

  • 6. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD.
    Zarling JM, Moran PA, Burke RL, Pachl C, Berman PW, Lasky LA.
    J Immunol; 1986 Jun 15; 136(12):4669-73. PubMed ID: 2423598
    [Abstract] [Full Text] [Related]

  • 7. Natural killer cells lyse autologous herpes simplex virus infected targets using cytolytic mechanisms distributed clonotypically.
    Pietra G, Semino C, Cagnoni F, Boni L, Cangemi G, Frumento G, Melioli G.
    J Med Virol; 2000 Nov 15; 62(3):354-63. PubMed ID: 11055246
    [Abstract] [Full Text] [Related]

  • 8. Role of interferon in human natural killer activity against target cells infected with HSV-1.
    Bishop GA, Glorioso JC, Schwartz SA.
    J Immunol; 1983 Oct 15; 131(4):1849-53. PubMed ID: 6194217
    [Abstract] [Full Text] [Related]

  • 9. Relationship between expression of herpes simplex virus glycoproteins and susceptibility of target cells to human natural killer activity.
    Bishop GA, Glorioso JC, Schwartz SA.
    J Exp Med; 1983 May 01; 157(5):1544-61. PubMed ID: 6189940
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of glycosylation of herpes simplex virus glycoproteins: identification of antigenic and immunogenic partially glycosylated glycopeptides on the cell surface membrane.
    Glorioso J, Szczesiul MS, Marlin SD, Levine M.
    Virology; 1983 Apr 15; 126(1):1-18. PubMed ID: 6189286
    [Abstract] [Full Text] [Related]

  • 11. Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection.
    Bystrická M, Petríková M, Zatovicová M, Soláriková L, Kostolanský F, Mucha V, Russ G.
    Acta Virol; 1997 Feb 15; 41(1):5-12. PubMed ID: 9199708
    [Abstract] [Full Text] [Related]

  • 12. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
    Yasukawa M, Zarling JM.
    J Immunol; 1984 Nov 15; 133(5):2736-42. PubMed ID: 6207243
    [Abstract] [Full Text] [Related]

  • 13. Antigenic variants of herpes simplex virus selected with glycoprotein-specific monoclonal antibodies.
    Holland TC, Marlin SD, Levine M, Glorioso J.
    J Virol; 1983 Feb 15; 45(2):672-82. PubMed ID: 6187935
    [Abstract] [Full Text] [Related]

  • 14. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
    Yasukawa M, Zarling JM.
    J Immunol; 1984 Jul 15; 133(1):422-7. PubMed ID: 6609990
    [Abstract] [Full Text] [Related]

  • 15. Role of interferon in natural kill of HSV-1-infected fibroblasts.
    Fitzgerald PA, von Wussow P, Lopez C.
    J Immunol; 1982 Aug 15; 129(2):819-23. PubMed ID: 6177785
    [Abstract] [Full Text] [Related]

  • 16. Alternative mechanisms of natural killer cell activation during herpes simplex virus infection.
    Paya CV, Schoon RA, Leibson PJ.
    J Immunol; 1990 Jun 01; 144(11):4370-5. PubMed ID: 2160501
    [Abstract] [Full Text] [Related]

  • 17. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
    Burns GF, Triglia T, Werkmeister JA.
    J Immunol; 1984 Sep 01; 133(3):1656-63. PubMed ID: 6611374
    [Abstract] [Full Text] [Related]

  • 18. Monoclonal antibodies against leucoagglutinin-reactive human T lymphocyte surface components. Two antibodies which inhibit cell-mediated cytotoxicity at a post-binding stage.
    Vargas-Cortes M, Hammarström ML, Hammarström S, Hellström U, Perlmann P.
    Eur J Immunol; 1986 Jul 01; 16(7):795-801. PubMed ID: 3522246
    [Abstract] [Full Text] [Related]

  • 19. Effects of herpes simplex virus on induced cell-mediated cytotoxicity in neonates and adults.
    Chin TW, Plaeger-Marshall S, Ank BJ, Pressman SR, Stiehm ER.
    Nat Immun Cell Growth Regul; 1991 Jul 01; 10(5):237-46. PubMed ID: 1661847
    [Abstract] [Full Text] [Related]

  • 20. Functional characterization of LFA-1 antigens in the interaction of human NK clones and target cells.
    Schmidt RE, Bartley G, Levine H, Schlossman SF, Ritz J.
    J Immunol; 1985 Aug 01; 135(2):1020-5. PubMed ID: 3924996
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.